Nigel W. Bunnett

1-100 Grattan Street
Parkville, VIC 3010, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 128 publications

Targeting Synaptic Vesicle Endocytosis in Nociceptors Provides Sustained Pain Relief.

Targeting Synaptic Vesicle Endocytosis in Nociceptors Provides Sustained Pain Relief.

Journal: bioRxiv : the preprint server for biology

Published: July 03, 2026

Inducible activation of PKA in osteoblasts causes a profound high bone turnover phenotype similar to human diseases.

Inducible activation of PKA in osteoblasts causes a profound high bone turnover phenotype similar to human diseases.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

ENDOSOMAL SIGNALING OF PROTEASE-ACTIVATED RECEPTOR-2 AMPLIFIES HISTAMINE-INDUCED PAIN OF IRRITABLE BOWEL SYNDROME.

ENDOSOMAL SIGNALING OF PROTEASE-ACTIVATED RECEPTOR-2 AMPLIFIES HISTAMINE-INDUCED PAIN OF IRRITABLE BOWEL SYNDROME.

Journal: bioRxiv : the preprint server for biology

Published: February 12, 2026

EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer.

EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer.

Journal: Science signaling

Published: January 27, 2026

EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer.

EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer.

Journal: Science signaling

Published: January 27, 2026

Endosomal signalling of protease-activated receptor-2 amplifies histamine-induced pain of irritable bowel syndrome.

Endosomal signalling of protease-activated receptor-2 amplifies histamine-induced pain of irritable bowel syndrome.

Journal: Gut

Published: December 28, 2025

Neuropilin-1 mediates nerve growth factor signaling of oral cancer pain.

Neuropilin-1 mediates nerve growth factor signaling of oral cancer pain.

Journal: Pain

Published: November 24, 2025

Neuropilin-1 mediates nerve growth factor signaling of oral cancer pain.

Neuropilin-1 mediates nerve growth factor signaling of oral cancer pain.

Journal: Pain

Published: November 24, 2025

Engineering Nanoscale Drug Delivery Systems for Pain.

Engineering Nanoscale Drug Delivery Systems for Pain.

Journal: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

Published: October 28, 2025

Nanomedicines targeting protease-activated receptor 2 in endosomes provide sustained analgesia.

Nanomedicines targeting protease-activated receptor 2 in endosomes provide sustained analgesia.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 07, 2025

Probing the activity of cysteine cathepsins in inflammatory bowel diseases.

Probing the activity of cysteine cathepsins in inflammatory bowel diseases.

Journal: Scientific reports

Published: September 19, 2025

Nanoparticle-mediated antagonism of sustained endosomal signaling of the calcitonin receptor-like receptor provides enhanced and persistent relief of oral cancer pain.

Nanoparticle-mediated antagonism of sustained endosomal signaling of the calcitonin receptor-like receptor provides enhanced and persistent relief of oral cancer pain.

Journal: Biomaterials

Published: July 08, 2025

Showing 1-12 of 128

Last Updated: 09/26/2026